An Observational Analysis of a Large Cohort of Pneumocystis jirovecii Pneumonia
Open Forum Infectious Diseases · 30.06.2025 · 12 (7)
DOI: 10.1093/ofid/ofaf390 ↗Kurz gefasst
Fachartikel in der Zeitschrift Open Forum Infectious Diseases, online erschienen am 03.07.2025. Verfasst von Aaron M Pulsipher und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Critical Care, Mayo Clinic, Phoenix, Arizona, USA. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS, NIAID NIH HHS, NCATS NIH HHS.
Abstract (Originalsprache)
Background
Pneumocystis jirovecii pneumonia (PCP) is increasingly seen in patients who are non-HIV immunocompromised hosts, yet modern risk factors and outcomes are poorly recognized and defined.
Methods
A retrospective review was conducted of adult patients who met criteria for proven or probable PCP from 2017 to 2024 across a large academic multicenter health system. The primary outcome was mortality among cohorts, defined by etiology of immunosuppression through univariate and age-adjusted logistic regression. Secondary analyses included trends in annual diagnoses and testing patterns.
Results
A total of 701 patients met criteria for inclusion, representing one of the largest clinically characterized cohorts of PCP to date. The median age was 65 years (IQR, 54–73) and 62% were male. The most common risk groups were hematologic malignancy (32.2%), solid tumor cancers receiving chemotherapy (22.4%), and autoimmune disease with immunosuppression (17.7%). Annual PCP diagnoses increased at a rate of 15.8% (95% CI, 8.9%–23.2%) in parallel with increased testing. Only 5.4% of patients were receiving prophylaxis at the time of diagnosis. Overall mortality was 20% (95% CI, 17%–23%) and highest in cirrhosis (adjusted odds ratio, 6.24; 95% CI, 2.84–13.69; P < .001).
Conclusions
PCP in the current era affects a broad range of patients who are immunocompromised, with high associated mortality and low rates of prophylaxis. Patients with solid tumors and those with cirrhosis are at particularly high risk of mortality. These findings highlight the need to reassess and redefine PCP prophylaxis guidelines in specific populations and our understanding of who is at risk.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Critical Care, Mayo Clinic, Phoenix, Arizona, USA.
- Division of Infectious Diseases and Transplant Center, Mayo Clinic, Phoenix, Arizona, USA.
- Division of Cardiothoracic Radiology, Mayo Clinic, Phoenix, Arizona, USA.
- Department of Internal Medicine, Mayo Clinic, Phoenix, Arizona, USA.
- Division of Clinical Trials and Biostatistics, Mayo Clinic, Phoenix, Arizona, USA.
- Division of Pulmonary and Critical Care, Mayo Clinic, Rochester, Minnesota, USA.
ORCID-Profile: Aaron M Pulsipher, Holenarasipur R Vikram, Michael B Gotway, Ryan R Gassner, Kevin Zhou, Dani B Green, Emily R Thompson, Ayan Sen, Augustine S Lee, Kealy Ham
Förderung
- NHLBI NIH HHS
- NIAID NIH HHS
- NCATS NIH HHS
- Center for Clinical and Translational Science
Zitieren
APA
Pulsipher, A. M., Vikram, H. R., Gotway, M. B., Cartin-Ceba, R., Henry, K. J., Johnson, A. M., Gassner, R. R., Zhou, K., Green, D. B., Thompson, E. R., Limper, A. H., Sen, A., Lee, A. S., & Ham, K. (2025). An Observational Analysis of a Large Cohort of Pneumocystis jirovecii Pneumonia. Open Forum Infectious Diseases, 12(7). https://doi.org/10.1093/ofid/ofaf390
Vancouver
Pulsipher AM, Vikram HR, Gotway MB, Cartin-Ceba R, Henry KJ, Johnson AM, et al. An Observational Analysis of a Large Cohort of Pneumocystis jirovecii Pneumonia. Open Forum Infectious Diseases. 2025;12(7). doi:10.1093/ofid/ofaf390
BibTeX
@article{Pulsipher2025,
author = {Pulsipher, Aaron M and Vikram, Holenarasipur R and Gotway, Michael B and Cartin-Ceba, Rodrigo and Henry, Kyle J and Johnson, Alec M and Gassner, Ryan R and Zhou, Kevin and Green, Dani B and Thompson, Emily R and Limper, Andrew H and Sen, Ayan and Lee, Augustine S and Ham, Kealy},
title = {An Observational Analysis of a Large Cohort of Pneumocystis jirovecii Pneumonia},
journal = {Open Forum Infectious Diseases},
year = {2025},
volume = {12},
number = {7},
doi = {10.1093/ofid/ofaf390}
}
EUVIMED